Bitterman Robert J 4
4 · Phio Pharmaceuticals Corp. · Filed May 23, 2025
Insider Transaction Report
Form 4
Bitterman Robert J
DirectorChairman, Pres. & CEO
Transactions
- Purchase
Common Stock, $0.0001 par value
2025-05-21$1.77/sh+3,000$5,310→ 22,449 total - Purchase
Common Stock, $0.0001 par value
2025-05-22$1.78/sh+1,200$2,136→ 23,649 total
Footnotes (2)
- [F1]Includes shares of common stock underlying unvested restricted stock units.
- [F2]The number of reported securities has been adjusted to reflect prior reverse stock splits.